Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia

被引:15
作者
Lee, JH [1 ]
Choi, SJ [1 ]
Lee, JH [1 ]
Lee, YS [1 ]
Seol, M [1 ]
Ryu, SG [1 ]
Lee, JS [1 ]
Kim, WK [1 ]
Lee, KH [1 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul 138736, South Korea
关键词
non-TBI; preparative regimen; alternative donor; BMT; severe aplastic anemia;
D O I
10.1038/sj.bmt.1704880
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Using non- total body irradiation ( TBI) containing preparative regimens, 13 patients with severe aplastic anemia ( SAA) were transplanted from an alternative donor in a single institute. In total, 12 donors were unrelated volunteers and one was an HLA one- locus mismatched sibling. Median time from diagnosis of SAA to bone marrow transplantation ( BMT) was 10.1 months ( range, 1.6 - 180.1). Nine patients had received immunosuppressive treatment with ATG before BMT, while four had not. Preparative regimens consisted of cyclophosphamide plus ATG in nine patients, cyclophosphamide plus fludarabine in two patients, and cyclophosphamide plus fludarabine plus ATG in two patients. All patients received non- T- cell depleted bone marrow from the donor. Cyclosporine plus methotrexate were given for GVHD prophylaxis. All patients engrafted on a median of day 21( range, 15 - 27). Grade III - IV acute GVHD developed in three ( 23%) of 13 patients and extensive chronic GVHD in four ( 31%) of 12 evaluable patients. With a median follow- up duration of 1138 days ( range, 118 - 1553), 10 patients are alive with durable engraftment showing 74.6% ( 95% confidence interval, 49.5 - 99.7%) of survival rate. Cause of the deaths was CNS bleeding in one and chronic GVHD in two. In conclusion, non- TBI containing preparative regimen could ensure durable engraftment in alternative donor BMT for SAA and showed promising results.
引用
收藏
页码:755 / 761
页数:7
相关论文
共 51 条
[1]   MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA - LONG-TERM OUTCOME IN 50 UNTRANSFUSED PATIENTS [J].
ANASETTI, C ;
DONEY, KC ;
STORB, R ;
MEYERS, JD ;
FAREWELL, VT ;
BUCKNER, CD ;
APPELBAUM, FR ;
SULLIVAN, KM ;
CLIFT, RA ;
DEEG, HJ ;
FEFER, A ;
MARTIN, PJ ;
SINGER, JW ;
SANDERS, JE ;
STEWART, PS ;
WITHERSPOON, RP ;
THOMAS, ED .
ANNALS OF INTERNAL MEDICINE, 1986, 104 (04) :461-466
[2]   ANTILYMPHOCYTE GLOBULIN, CYCLOSPORINE, AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH ACQUIRED SEVERE APLASTIC-ANEMIA (SAA) - A PILOT-STUDY OF THE EBMT SAA WORKING PARTY [J].
BACIGALUPO, A ;
BROCCIA, G ;
CORDA, G ;
ARCESE, W ;
CAROTENUTO, M ;
GALLAMINI, A ;
LOCATELLI, F ;
MORI, PG ;
SARACCO, P ;
TODESCHINI, G ;
COSER, P ;
IACOPINO, P ;
VANLINT, MT ;
GLUCKMAN, E .
BLOOD, 1995, 85 (05) :1348-1353
[3]   PREVENTION OF TRANSFUSION-INDUCED SENSITIZATION TO MINOR HISTOCOMPATIBILITY ANTIGENS ON DLA-IDENTICAL CANINE MARROW GRAFTS BY GAMMA-IRRADIATION OF MARROW DONOR BLOOD [J].
BEAN, MA ;
STORB, R ;
GRAHAM, T ;
RAFF, R ;
SALE, GE ;
SCHUENING, F ;
APPELBAUM, FR .
TRANSPLANTATION, 1991, 52 (06) :956-960
[4]   Gamma radiation of blood products prevents rejection of subsequent DLA-identical marrow grafts - Tolerance versus abrogation of sensitization to non-DLA antigens [J].
Bean, MA ;
Graham, T ;
Appelbaum, FR ;
Deeg, HJ ;
Schuening, F ;
Sale, GE ;
Leisenring, W ;
Pepe, M ;
Storb, R .
TRANSPLANTATION, 1996, 61 (02) :334-335
[5]   GAMMA-IRRADIATION OF PRETRANSPLANT BLOOD-TRANSFUSIONS FROM UNRELATED DONORS PREVENTS SENSITIZATION TO MINOR HISTOCOMPATIBILITY ANTIGENS ON DOG LEUKOCYTE ANTIGEN-IDENTICAL CANINE MARROW GRAFTS [J].
BEAN, MA ;
GRAHAM, T ;
APPELBAUM, FR ;
DEEG, HJ ;
SCHUENING, F ;
SALE, GE ;
STORB, R .
TRANSPLANTATION, 1994, 57 (03) :423-426
[6]   THE SYNDROME OF HEPATIC VENOOCCLUSIVE DISEASE AFTER MARROW TRANSPLANTATION [J].
BEARMAN, SI .
BLOOD, 1995, 85 (11) :3005-3020
[7]  
CAMITTA BM, 1975, BLOOD, V45, P355
[8]  
CHAMPLIN RE, 1989, BLOOD, V73, P606
[9]   A fludarabine-based conditioning regimen for severe aplastic anemia [J].
Chan, KW ;
Li, CK ;
Worth, LL ;
Chik, KW ;
Jeha, S ;
Shing, MK ;
Yuen, PM .
BONE MARROW TRANSPLANTATION, 2001, 27 (02) :125-128
[10]   Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study [J].
Choi, SJ ;
Lee, KH ;
Lee, JH ;
Kim, S ;
Chung, HJ ;
Lee, JS ;
Kim, SH ;
Park, CJ ;
Chi, HS ;
Kim, WK .
BONE MARROW TRANSPLANTATION, 2000, 26 (03) :327-332